Fosravuconazole L-lysine ethanolate
Fosravuconazole L-lysine ethanolate is a prodrug of the broad-spectrum antifungal ravuconazole. It is clinically approved in Japan for treating onychomycosis and is used in research to study antifungal efficacy in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
914361-45-8
Product Name Alternative
E-1224 L-lysine Ethanolate, E-1224 L-lysine ethanolate, antifungal, candidiasis, BMS-379224 L-lysine ethanolate, BMS-379224 L-lysine Ethanolate, Fosravuconazole L lysine ethanolate, Fosravuconazole L-lysine, Fosravuconazole Llysine ethanolate, Fosravuconazole L-lysine Ethanolate, Fungal, Inhibitor, onychomycosis, Parasite, parasitemia, inhibit, Ravuconazole
Field of Research
Infectious Disease & Virology, Pharmacology & Drug Discovery
Purity
95.00% (May vary between batches)
Solubility
DMSO:48 mg/mL (64.89 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (2.7 mM)
Smiles
N#CC1=CC=C (C2=CSC ([C@H] (C) [C@@] (OCOP (O) (O) =O) (C3=CC=C (F) C=C3F) CN4N=CN=C4) =N2) C=C1.CCO.N[C@H] (C (O) =O) CCCCN
Molecular Formula
C31H40F2N7O8PS
Molecular Weight
739.7
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470257-100 1x 100 µL
Cytokeratin, HMW (AE-3), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880050-100 1x 100 µL
IgA Secretory Component (SC05), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040745-100 1x 100 µL
CD45 / LCA (2B11 + PD7/26), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680226-500 1x 500 µL
Pmel17 / gp100 / SILV (NKI-beteb), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details